{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ACE 2 receptor", "Andrographolide", "NSP12", "RBD", "SARS-CoV-2"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34255214", "DateRevised": {"Year": "2023", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "13"}], "Language": ["eng"], "ELocationID": ["101", "10.1186/s43141-021-00201-7"], "Journal": {"ISSN": "2090-5920", "JournalIssue": {"Volume": "19", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jul", "Day": "13"}}, "Title": "Journal, genetic engineering & biotechnology", "ISOAbbreviation": "J Genet Eng Biotechnol"}, "ArticleTitle": "Andrographolide binds to spike glycoprotein and RNA-dependent RNA polymerase (NSP12) of SARS-CoV-2 by in silico approach: a probable molecule in the development of anti-coronaviral drug.", "Pagination": {"StartPage": "101", "MedlinePgn": "101"}, "Abstract": {"AbstractText": ["The SARS-CoV-2 belongs to Coronaviridae family infects host cells by the interaction of its spike glycoprotein and angiotensin-converting enzyme 2 (ACE 2) of host cells. Upon entry, the virus uses its RNA dependent RNA polymerase (NSP12) for transcribing its genome to survive in the cell and spread its infection. The protein sequences of receptor-binding domain (RBD) of spike glycoprotein, and NSP12 exhibits high homology in the family of Coronoviridae and are ideal candidates for the development of anti-coronaviral drugs. In the quest to identify inhibitory molecules against these proteins, we searched several molecules that are present in naturally occurring medicinal plants database. Andrographolide which is largely present in the leaf extracts of Andrographis paniculata (AP) and is known to exhibit antiviral, antibacterial, and stabilizes Th1/Th2/Th17 responses; taking this clue, we used in silico approaches to see the binding of andrographolide to RBD and NSP12 molecules. Our docking results showed very strong affinity of andrographolide to RBD and NSP12 of the SARS-CoV-2 virus with dock scores of -10.3460 for RBD and -10.7313 for NSP12 indicating andrographolide acts as an inhibitor of RBD and NSP12. These unique properties of andrographolide, AP extract, can be tested as anti-coronaviral drug."], "CopyrightInformation": "\u00a9 2021. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Sri Venkateswara Institute of Medical Sciences and University, Tirupati, Andhra Pradesh, 517507, India."}], "LastName": "Srikanth", "ForeName": "Lokanathan", "Initials": "L"}, {"Identifier": ["0000-0001-9991-0773"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Sri Venkateswara Institute of Medical Sciences and University, Tirupati, Andhra Pradesh, 517507, India. pvgksarmasvims@gmail.com."}], "LastName": "Sarma", "ForeName": "Potukuchi Venkata Gurunadha Krishna", "Initials": "PVGK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "J Genet Eng Biotechnol", "NlmUniqueID": "101317150", "ISSNLinking": "1687-157X"}, "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270\u2013273. doi: 10.1038/s41586-020-2012-7.", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265\u2013269. doi: 10.1038/s41586-020-2008-3.", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Luan J, Jin X, Lu Y, Zhang L (2020) SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae [published online ahead of print, 2020 Apr 1]. J Med Virol. 10.1002/jmv.25817", "ArticleIdList": ["PMC7228376", "32239522"]}, {"Citation": "Ortega JT, Serrano ML, Pujol FH, Rangel HR. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: an in silico analysis. EXCLI J. 2020;19:410\u2013417. doi: 10.17179/excli2020-1167.", "ArticleIdList": ["10.17179/excli2020-1167", "PMC7081066", "32210742"]}, {"Citation": "Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53(3):368\u2013370. doi: 10.1016/j.jmii.2020.03.005.", "ArticleIdList": ["10.1016/j.jmii.2020.03.005", "PMC7156211", "32205092"]}, {"Citation": "Li F. Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol. 2016;3(1):237\u2013261. doi: 10.1146/annurev-virology-110615-042301.", "ArticleIdList": ["10.1146/annurev-virology-110615-042301", "PMC5457962", "27578435"]}, {"Citation": "Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26(4):450\u2013452. doi: 10.1038/s41591-020-0820-9.", "ArticleIdList": ["10.1038/s41591-020-0820-9", "PMC7095063", "32284615"]}, {"Citation": "Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochem Biophys Res Commun. 2020;525(1):135\u2013140. doi: 10.1016/j.bbrc.2020.02.071.", "ArticleIdList": ["10.1016/j.bbrc.2020.02.071", "PMC7092824", "32081428"]}, {"Citation": "Kirchdoerfer RN, Ward AB. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun. 2019;10:2342. doi: 10.1038/s41467-019-10280-3.", "ArticleIdList": ["10.1038/s41467-019-10280-3", "PMC6538669", "31138817"]}, {"Citation": "Scavone C, Brusco S, Bertini M et al (2020); [published online ahead of print, 2020 Apr 24]) Current pharmacological treatments for COVID-19: what\u2019s next? Br J Pharmacol. 10.1111/bph.15072", "ArticleIdList": ["PMC7264618", "32329520"]}, {"Citation": "Beigel JH, Tomashek KM, Dodd LE et al (2020) [published online ahead of print, 2020 May 22) Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med. 10.1056/NEJMoa2007764", "ArticleIdList": ["32649078"]}, {"Citation": "Jayakumar T, Hsieh CY, Lee JJ, Sheu JR. Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid Based Complement Alternat Med. 2013;2013:846740.", "ArticleIdList": ["PMC3619690", "23634174"]}, {"Citation": "Nie X, Chen SR, Wang K, Peng Y, Wang YT, Wang D, Wang Y, Zhou GC. Attenuation of innate immunity by andrographolide derivatives through NF-\u03baB signalling pathway. Sci Rep. 2017;7(1):4738. doi: 10.1038/s41598-017-04673-x.", "ArticleIdList": ["10.1038/s41598-017-04673-x", "PMC5498490", "28680097"]}, {"Citation": "Zhu Q, Zheng P, Zhou J, Chen X, Feng Y, Wang W, Zhou F, He Q. Andrographolide affects Th1/Th2/Th17 responses of peripheral blood mononuclear cells from ulcerative colitis patients. Mol Med Rep. 2018;18(1):622\u2013626. doi: 10.3892/mmr.2018.8992.", "ArticleIdList": ["10.3892/mmr.2018.8992", "29749556"]}, {"Citation": "Rajani M, Shrivastava N, Ravishankara MN. A rapid method for isolation of andrographolide from Andrographis paniculata Nees (kalmegh) Pharm Biol. 2000;38(3):204\u2013209. doi: 10.1076/1388-0209(200007)3831-SFT204.", "ArticleIdList": ["10.1076/1388-0209(200007)3831-SFT204", "21214463"]}, {"Citation": "Wu K, Li W, Peng G, Li F. Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor. Proc Natl Acad Sci U S A. 2009;106(47):19970\u201319974. doi: 10.1073/pnas.0908837106.", "ArticleIdList": ["10.1073/pnas.0908837106", "PMC2785276", "19901337"]}, {"Citation": "Ang L, Lee HW, Choi JY, Zhang J, Soo Lee M. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res. 2020;9(2):100407. doi: 10.1016/j.imr.2020.100407.", "ArticleIdList": ["10.1016/j.imr.2020.100407", "PMC7104236", "32289016"]}, {"Citation": "Iwasaki A, Yang Y. The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol. 2020;20(6):339\u2013341. doi: 10.1038/s41577-020-0321-6.", "ArticleIdList": ["10.1038/s41577-020-0321-6", "PMC7187142", "32317716"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "6", "Day": "12"}, {"Year": "2021", "Month": "6", "Day": "19"}, {"Year": "2021", "Month": "7", "Day": "13", "Hour": "12", "Minute": "27"}, {"Year": "2021", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "14", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "7", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["34255214", "PMC8276218", "10.1186/s43141-021-00201-7", "10.1186/s43141-021-00201-7"]}}], "PubmedBookArticle": []}